Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

An Arg-Gly-Asp peptide stimulates Ca2+ efflux from osteoclast precursors through a novel mechanism

An Arg-Gly-Asp peptide stimulates Ca2+ efflux from osteoclast precursors through a novel mechanism KENSUKE YAMAKAWA, RANDALL DUNCAN, Renal Division, Jewish Hospital at Washington St. Louis, Missouri 63110 Yamakawa, Kensuke, Randall Duncan, and Keith A. Hruska. An Arg-Gly-Asp peptide stimulates from osteoclast precursors through a novel mechanism. Am. J. Physiol. 266 (Renal Fluid Electrolyte PhysioZ. 35): F651F657, 1994.-We examined the effect of a peptide containing the Arg-Gly-Asp () on 45 from osteoclast precursors. 45-loaded osteoclast precursors were treated with (170 PM) for 10 min after 30 min of basal perfusion with a bicarbonate-containing buffer. significantly increased fractional of from treated cells compared with vehicle-treated cells (P < 0.01) or cells treated with up to 200 pg/ml of a control peptide containing GRGESP. The effect of was sustained for 15 min after the peptide was removed from the perfusate, but control levels of returned by 1 h. The effect of was most likely due to activation of the plasma membrane -adenosinetriphosphatase (-ATPase) pump, as indicated by its inhibition with vanadate and a calmodulin antagonist, N-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide, and the absence of an effect of Na+/ exchange inhibition. An inhibitor of cyclic. nucleotide-dependent protein kinases, N-[2-(methylamino)ethyl]-5-isoquinolinesulfonamide (0.1 mM), failed to inhibit - . However, genistein and herbimycin A, inhibitors of protein-tyrosine kinases, blocked by . The http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png AJP - Renal Physiology The American Physiological Society

An Arg-Gly-Asp peptide stimulates Ca2+ efflux from osteoclast precursors through a novel mechanism

Loading next page...
 
/lp/the-american-physiological-society/an-arg-gly-asp-peptide-stimulates-ca2-efflux-from-osteoclast-wNPq39FX2S

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
The American Physiological Society
Copyright
Copyright © 1994 the American Physiological Society
ISSN
0363-6127
eISSN
1522-1466
Publisher site
See Article on Publisher Site

Abstract

KENSUKE YAMAKAWA, RANDALL DUNCAN, Renal Division, Jewish Hospital at Washington St. Louis, Missouri 63110 Yamakawa, Kensuke, Randall Duncan, and Keith A. Hruska. An Arg-Gly-Asp peptide stimulates from osteoclast precursors through a novel mechanism. Am. J. Physiol. 266 (Renal Fluid Electrolyte PhysioZ. 35): F651F657, 1994.-We examined the effect of a peptide containing the Arg-Gly-Asp () on 45 from osteoclast precursors. 45-loaded osteoclast precursors were treated with (170 PM) for 10 min after 30 min of basal perfusion with a bicarbonate-containing buffer. significantly increased fractional of from treated cells compared with vehicle-treated cells (P < 0.01) or cells treated with up to 200 pg/ml of a control peptide containing GRGESP. The effect of was sustained for 15 min after the peptide was removed from the perfusate, but control levels of returned by 1 h. The effect of was most likely due to activation of the plasma membrane -adenosinetriphosphatase (-ATPase) pump, as indicated by its inhibition with vanadate and a calmodulin antagonist, N-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide, and the absence of an effect of Na+/ exchange inhibition. An inhibitor of cyclic. nucleotide-dependent protein kinases, N-[2-(methylamino)ethyl]-5-isoquinolinesulfonamide (0.1 mM), failed to inhibit - . However, genistein and herbimycin A, inhibitors of protein-tyrosine kinases, blocked by . The

Journal

AJP - Renal PhysiologyThe American Physiological Society

Published: Apr 1, 1994

There are no references for this article.